XBiotech XBIT
NASDAQ XBIT
$2.19 +0.01 (+0.46%)
At close: Sep 30, 2026 · 4:00 PM EDT

XBiotech (XBIT) Non-Current Deferred Tax Liability (2021 - 2026)

Updated

XBiotech (XBIT) posted Non-Current Deferred Tax Liability of $5,000 for Q2 2026.

Analysis

XBiotech (XBIT) Non-Current Deferred Tax Liability (2021 - 2026) Analysis & Trends

Since Q2 2021, XBiotech has reported Non-Current Deferred Tax Liability for 9 quarters.

  • Annual Non-Current Deferred Tax Liability shows a four-year compound annual growth rate of -72.5% (FY2021 to FY2025).
  • In prior years, XBiotech's Non-Current Deferred Tax Liability was $59,000 in FY2022 (-93.2%) and $873,000 in FY2021.
  • Quarterly Non-Current Deferred Tax Liability has run from a low of $5,000 in Q4 2025 to a high of $873,000 in Q2 2022 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 XBiotech 66.77 Mn 66.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5,000.00
Dec 31, 2025 5,000.00
Dec 31, 2022 59,000.00
Sep 30, 2022 872,000.00
Jun 30, 2022 873,000.00
Mar 31, 2022 873,000.00
Dec 31, 2021 873,000.00
Sep 30, 2021 108,000.00
Jun 30, 2021 108,000.00
API Access

XBiotech Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=XBIT&period=max&api_key=YOUR_API_KEY